Glaucoma Treatment: LUMIGAN

Healthcare Professionals

Full Prescribing Information

Glossary

Register

Unsubscribe

Test

Your Eyesight

About LUMIGAN^®

Tools and Resources

Full Prescribing Information

For patients with open-angle glaucoma or ocular hypertension, LUMIGAN

ophthalmic solution can help reduce increased eye pressure, which is the only treatable glaucoma risk factor. LUMIGAN

is a medication prescribed to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

If your doctor has prescribed LUMIGAN

ophthalmic solution to lower your IOP, register to receive LUMIGAN

prescription refill reminders and treatment reminders. You'll also receive the LUMIGAN

New Patient e-mail series. These ongoing e-newsletters are full of information about glaucoma symptoms, glaucoma treatment, and the role of LUMIGAN

ophthalmic solution in treating eye pressure associated with open-angle glaucoma and ocular hypertension. To register, simply click here.

Are you currently a LUMIGAN® patient?

Yes, I am currently taking LUMIGAN®

No, I am not a LUMIGAN® patient

No, I am a physician

No, I am a caregiver of someone who takes LUMIGAN®

Other

LUMIGAN (bimatoprost ophthalmic solution) 0.03% is for the treatment of high eye pressure, also called intraocular pressure (IOP), in people with open-angle glaucoma or ocular hypertension.

Important Safety Information
LUMIGAN (bimatoprost ophthalmic solution) 0.03% has been reported to cause darkening (pigmentation) of eye color, eyelid skin and eyelashes, as well as increased growth of eyelashes. Pigmentation changes can increase as long as LUMIGAN is used. After stopping LUMIGAN®, darkening of eye color is likely to be permanent while darkening of the eyelid skin and eyelash changes may be reversible. The effects of increased darkening beyond 5 years are not known.

The most common side effects are eye redness, growth of eyelashes, and itchy eyes.